Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Avigan

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinical Advances in Hematology & Oncology : H&O|December 19, 2019
Advances in the development of vaccines and other immunotherapies for multiple myelomaDavid E Avigan
International Journal of Hematology|March 25, 2023
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapyBrian M Russell, David E Avigan
Human Vaccines & Immunotherapeutics|January 28, 2015
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignanciesAthalia R Pyzer, David E Avigan, Jacalyn Rosenblatt
Current Opinion in Gastroenterology|October 13, 2006
Update on cancer vaccinesVirginia F Borges, Donald Kufe, David E Avigan
International Journal of Cancer|June 15, 2016
Myeloid-derived suppressor cells as effectors of immune suppression in cancerAthalia Rachel Pyzer, Leandra Cole, Jacalyn Rosenblatt, et al.
Expert Review of Hematology|January 15, 2014
Immunotherapy for multiple myelomaJacalyn Rosenblatt, Michal Bar-Natan, Nikhil C Munshi, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2021
Case Report: Refractory Cryptosporidiosis after CAR T-Cell Therapy for LymphomaCaitlin A Trottier, Christina F Yen, Grace Malvar, et al.
Journal of Clinical Apheresis|April 30, 2003
Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood culturesMitchell J Schwaber, Carolyn N Krasner, Howard S Gold, et al.
Immunotherapy|July 10, 2026
CD137 in cancer therapy - bench to bedsideKathrine S Rallis, Jessica J Liegel, Alexandra Pommier, et al.
AJR. American Journal of Roentgenology|April 23, 2011
Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CTJay K Pahade, Christina A LeBedis, Vassilios D Raptopoulos, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinical Advances in Hematology & Oncology : H&O|December 19, 2019
Advances in the development of vaccines and other immunotherapies for multiple myelomaDavid E Avigan
International Journal of Hematology|March 25, 2023
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapyBrian M Russell, David E Avigan
Human Vaccines & Immunotherapeutics|January 28, 2015
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignanciesAthalia R Pyzer, David E Avigan, Jacalyn Rosenblatt
Current Opinion in Gastroenterology|October 13, 2006
Update on cancer vaccinesVirginia F Borges, Donald Kufe, David E Avigan
International Journal of Cancer|June 15, 2016
Myeloid-derived suppressor cells as effectors of immune suppression in cancerAthalia Rachel Pyzer, Leandra Cole, Jacalyn Rosenblatt, et al.
Expert Review of Hematology|January 15, 2014
Immunotherapy for multiple myelomaJacalyn Rosenblatt, Michal Bar-Natan, Nikhil C Munshi, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2021
Case Report: Refractory Cryptosporidiosis after CAR T-Cell Therapy for LymphomaCaitlin A Trottier, Christina F Yen, Grace Malvar, et al.
Journal of Clinical Apheresis|April 30, 2003
Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood culturesMitchell J Schwaber, Carolyn N Krasner, Howard S Gold, et al.
Immunotherapy|July 10, 2026
CD137 in cancer therapy - bench to bedsideKathrine S Rallis, Jessica J Liegel, Alexandra Pommier, et al.
AJR. American Journal of Roentgenology|April 23, 2011
Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CTJay K Pahade, Christina A LeBedis, Vassilios D Raptopoulos, et al.
Pageof 5